Related Experiment Video
Updated: Sep 10, 2025
10:33
Assessment of Right Ventricular Structure and Function in Mouse Model of Pulmonary Artery Constriction by Transthoracic Echocardiography
Published on: February 3, 2014
28.0K
Noninvasive Estimation of Pulmonary Vascular Resistance Using Right Ventricular Outflow Doppler Analysis
Luis Afonso1, Chandra Kanth Ala1, Aditya Sood1
1Department of Medicine, Division of Cardiology, Wayne State University, Detroit, Michigan, USA.
JACC. Advances
|August 19, 2025
Summary
A new echocardiogram method accurately estimates pulmonary vascular resistance (PVR) using Doppler notch analysis. This noninvasive technique shows promise for guiding pulmonary hypertension diagnosis and management.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Medical Imaging
Background:
- Right heart catheterization (RHC) is the gold standard for measuring pulmonary vascular resistance (PVR).
- Current noninvasive methods for PVR assessment lack accuracy, particularly in moderate to severe pulmonary arterial hypertension.
Purpose of the Study:
- To develop and validate a novel echocardiographic method for estimating PVR.
- Utilize right ventricular outflow tract Doppler notch analysis for noninvasive PVR assessment.
Main Methods:
- Prospective study of 54 patients with interpretable Doppler data undergoing RHC and echocardiography.
- Analysis of right ventricular outflow tract Doppler notch time (NT) to ejection time ratio.
- Development of a regression equation for non-invasive PVR (niPVR) and validation against invasive PVR (iPVR).
Main Results:
- The inverse of NT was the strongest predictor of iPVR (R² = 0.93).
- The derived equation for niPVR showed superior performance and agreement compared to 5 established methods (r = 0.76, P < 0.0001).
- The method demonstrated strong correlation and superior agreement with invasive PVR measurements.
Conclusions:
- A novel echocardiographic method provides feasible, rapid, and reliable PVR estimation.
- This noninvasive technique may help identify candidates for invasive testing and guide pulmonary hypertension management.
- Further multicenter validation is recommended for broader application.
